Full Text
Cost-Effectiveness and Budget-Impact Analysis of Braf Inhibitors in Patients With Metastatic Malignant Melanoma (MMM) in Slovenia

Abstract

Authors

R. Hren

Back to Volume 17, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×